Publication | Open Access
Senkyunolide A inhibits the progression of osteoarthritis by inhibiting the NLRP3 signalling pathway
28
Citations
33
References
2022
Year
SenA alleviates OA progression by inhibiting NLRP3 signalling pathways. These findings provide an experimental basis for the clinical application of drugs in the treatment of OA.
| Year | Citations | |
|---|---|---|
Page 1
Page 1